Appointment New Patient Appointment or 214-645-8300

More Blogs

MedBlog

Cancer Pain Management

Ask the dietitian: How can good nutrition help cancer patients?

Eating a high-protein, low-fat diet can help cancer patients deal with the treatments and recovery, says a UT Southwestern oncology dietitian.

3 ways oncologists can improve survivorship care after cancer treatment

As cancer care improves, more people are living with survivorship symptoms, such as fatigue and depression. See 3 ways providers can help patients prepare for life after treatment.

Ortho-oncology: Improving care for patients with metastatic bone disease

Metastatic bone disease patients find hope with orthopaedic surgery options to decrease fracture risk, improve mobility, and manage pain. Alexandra Callan, M.D., discusses treatment advances and paradigm shifts over the last decade.

UT Southwestern: A global leader in robotic pancreas surgery

Robotic-assisted Whipple surgery for pancreatic cancer is one of the most complex GI procedures – and UT Southwestern is a leader in this field, training U.S. and international surgeons. Explore our Simulation Center and how robotic surgery can benefit patients.

Taking aim at fatty liver, cancer with new blood test

UT Southwestern has developed a simple blood test that can predict which patients with nonalcoholic fatty liver disease are most likely to develop liver cancer.

The ART and science of targeting gynecologic tumors

A new radiation therapy approach offers curative potential for gynecologic tumors. Learn about adaptive radiation therapy (ART) and two clinical trials at UT Southwestern to help women with cancer.

New immunotherapy can prevent kidney cancer recurrence after surgery: Is it right for you?

The FDA has approved pembrolizumab immunotherapy, the first treatment to lower kidney cancer recurrence risk after surgery. UT Southwestern's Dr. Hans Hammers helps patients explore its benefits and risks.

Coming of age with cancer: ACE helps young survivors thrive

Daniel Bowers, M.D., Medical Director of the After the Cancer Experience program, discusses the importance of lifelong care for childhood cancer survivors.

Sugar, inflammation, and soy: How does nutrition influence breast cancer risk?

Suzanne Conzen, M.D., explains how eating a healthy diet composed mainly of plant-based foods can be an effective way to help prevent breast cancer.

PARP-1 inhibitors can reduce ovarian cancer recurrence risk by 70% in half of patients

PARP-1 inhibitor drugs can reduce the risk of BRCA- and HRDS-associated ovarian cancer by 70%. New research at UT Southwestern Medical Center may help expand treatment to more patients.

TULSA treats prostate cancer with no incisions, surgery, or radiation

Men with localized, low- and intermediate-risk prostate cancer are seeking TULSA: an outpatient, alternative to surgery or active surveillance: no incisions, surgery, or radiation required. Learn more.

Lung cancer in young nonsmokers is on the rise: Uncovering the cause

U.S #lungcancer rates have declined for decades, except in one group: Young adults who never smoked. Jonathan Dowell, M.D., discusses what we know about the risks, as well as ongoing research to reveal more answers.

No smoke & mirrors: Vaping increases COVID-19 risks in young adults

New research shows that vaping increases the risk of COVID-19 infection and serious complications. Explore the data and get help quitting – virtually.

Immunotherapy and the marathon against melanoma: Terry's story

Immunotherapy has dramatically improved melanoma survival rates. In this week's MedBlog, Terry Hart tells his story of surviving advanced melanoma through immunotherapy.

Hepatitis C treatment can cut risk of liver-related death by 50% for patients with a history of liver cancer

This study looked at medical records for patients who were cured of liver cancer at 31 North American medical centers. The findings demonstrate that patients who were treated and cured of their hepatitis C had significantly better survival rates than those patients whose hepatitis C was not treated.